SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending following significant news regarding a government directive to buy $200 billion in mortgage bonds, aimed at driving down interest rates and revitalizing the housing market. This potential boost to affordability and transaction volume has ignited strong bullish sentiment and talk of a substantial run among community members. While many anticipate a major squeeze, some investors are mindful of potential warrant-related dilution at higher price levels.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is seeing intense discussion after eliminating its convertible debt, a move that many in the community believe strengthens its balance sheet and removes a key dilution overhang. This catalyst is fueling strong bullish sentiment, with traders actively debating a potential short squeeze due to high cost-to-borrow and limited share availability for the blockchain-enabled traceability company, despite ongoing skepticism regarding its profitability and historical volatility.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is trending after its AI chip unit, Kunlunxin, confidentially filed for an IPO in Hong Kong, leading many to anticipate a significant unlocking of value for the company. The community is buzzing with bullish sentiment, highlighting Baidu's leadership in AI and autonomous driving, as well as China's strategic push for domestic semiconductor independence, though some investors remain wary of historical volatility.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is gaining traction following its prominent role in the "MEMES ARE BACK" X Spaces event hosted by @Cryptotwits, drawing significant community attention. Enthusiasts are consistently bullish, driving conversation around the "KENDU SENDU" mantra and emphasizing the project's unique real-world presence through products like Kendu Spice and Kendu Energy drinks. This relentless community building and expansion across multiple blockchain networks signal strong potential for growth and continued visibility.

Bakkt Holdings, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt Holdings was founded in 2018 and is headquartered in New York, NY.

Bakkt Holdings Inc. - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt is drawing attention due to strategic moves, including a partnership to expand its digital asset infrastructure in the U.S. and an investment to establish a regulated gateway into the Indian market. The community is actively discussing these global growth opportunities, alongside speculation around stablecoin adoption and potential short squeezes, while some investors express frustration over past volatility and the desire for more frequent business updates.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending as the market digests both promising news and skepticism, particularly following a Nightline report on GLP-1s for addiction treatment which has fueled bullish outlooks for the company's expanding personalized healthcare platform. Despite a recent analyst downgrade and ongoing concerns about competition and management, many investors are seizing the current dip as a buying opportunity, anticipating a rebound driven by strong fundamentals, international expansion, and significant short interest. The community is sharply divided between those confident in its long-term growth and those anticipating further price declines.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending following its recent financial guidance for 2026 and 2027, which projects a significant revenue adjustment for DefenCath due to the anticipated change in reimbursement structure. The community is sharply divided, with many expressing frustration over the perceived conservatism of the outlook and criticisms aimed at management, while others argue the market reaction is overdone given prior awareness of the "TDAPA cliff" and potential legislative offsets or diversification from recent acquisitions.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is trending amidst escalating global tensions, particularly concerning China's rare earth export restrictions and the strategic importance of these minerals for US national security. The community anticipates a significant surge across the rare earth sector, driven by geopolitical developments like US actions in Venezuela and renewed interest in Greenland's resources, underscoring the urgent need for mineral independence. Investors are keenly watching USAR's progress with its Stillwater magnet plant and its leadership, positioning it as a critical player in establishing a robust US rare earth ecosystem.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies is experiencing strong trending activity, fueled by a prominent political figure's pledge to lower mortgage rates and inject substantial capital into the housing market. The community is highly bullish, anticipating a significant refinance boom and potential short squeeze, with many viewing RKT's integrated platform and strategic acquisitions as key advantages for substantial upside in the evolving mortgage sector.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is a focal point as the market awaits a key Supreme Court ruling on tariffs and the latest jobs data, with community discussion fiercely debating their potential for market-moving volatility. Adding to the churn, recent administration directives on mortgage bonds are also fueling speculation, as investors navigate a complex landscape of economic signals and political influence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Telemark Asset Management LLC Increases Stock Position in Codexis, Inc. $CDXS

Telemark Asset Management LLC lifted its position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 33.3% during the second quarter, according to its most recent disclosure with the...

Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS)

Codexis (CDXS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Codexis (NASDAQ:CDXS) Rating Lowered to "Strong Sell" at Wall Street Zen

Wall Street Zen downgraded shares of Codexis from a "hold" rating to a "strong sell" rating in a research report on Saturday...

Codexis (NASDAQ:CDXS) Issues Quarterly Earnings Results, Misses Expectations By $0.07 EPS

Codexis (NASDAQ:CDXS - Get Free Report) issued its earnings results on Thursday. The biotechnology company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by...

Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of -46.67% and -53.96%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Misses Revenue Estimates

EyePoint Pharmaceuticals (EYPT) delivered earnings and revenue surprises of -10.39% and -85.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Beats Revenue Estimates

Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of +14.29% and +2.80%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis Manufacturing Platform for Therapeutic siRNA Manufacturing

Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis Manufacturing Platform for Therapeutic siRNA Manufacturing Codexis and Nitto Denko Avecia Enter Evaluation...

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of +5.88% and +2.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates

BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of -6.52% and -52.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Codexis Inc.

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$1.68
Prev Close	$1.70
Open	$1.70
Dividend Yield	0.00%
50-Day Moving Average	$1.78
Beta	2.14
Avg. Volume	1.17M
PE Ratio	-2.24

52-Week High	$5.43
52-Week Low	$1.52
Market Capitalization	$153.55M
EPS (Annual)	-$0.8892
Price to Book	3.94
Revenue Per Employee	$315,664.89
Enterprise Value/EBITDA	N/A

CDXS
Codexis Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CDXS News

CDXSCodexis Inc.